Editorial
Eluxadoline: a promising therapy that raises many questions
Translational Gastroenterology and Hepatology
2016;
1:
76
.
(28 September 2016)
Editorial
Pathologic tumor response to neoadjuvant chemotherapy in gastroesophageal cancer: what does it mean?
Translational Gastroenterology and Hepatology
2016;
1:
75
.
(23 September 2016)
Case Report
Interventional therapy for rectal neuroendocrine tumor with liver metastases: report of one case
Translational Gastroenterology and Hepatology
2016;
1:
74
.
(23 September 2016)
Case Report
Metastatic multiple endocrine neoplasia type 1: report of one case
Translational Gastroenterology and Hepatology
2016;
1:
73
.
(23 September 2016)
Editorial
Splenic hilar dissection in the treatment of proximal advanced gastric cancer: what is an adequate strategy?
Translational Gastroenterology and Hepatology
2016;
1:
72
.
(21 September 2016)
Commentary
Impact of pathologic tumor response in the treatment of gastric cancer
Translational Gastroenterology and Hepatology
2016;
1:
71
.
(21 September 2016)
Case Report
Glucagonoma syndrome: report of one case
Translational Gastroenterology and Hepatology
2016;
1:
70
.
(19 September 2016)
Review Article
Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer
Translational Gastroenterology and Hepatology
2016;
1:
69
.
(19 September 2016)
Editorial
Surgery for liver metastasis from gastric cancer
Translational Gastroenterology and Hepatology
2016;
1:
68
.
(08 September 2016)
Review Article
Targeting angiogenesis in gastrointestinal tumors: current challenges
Translational Gastroenterology and Hepatology
2016;
1:
67
.
(06 September 2016)